News room - Whats been happening?

From new centres and equipment to the latest in care, stay on top with what we are doing

Radiotherapy: a valuable tool in a time of crisis

31 March, 2020

Our SABR UK clinical director of stereotactic radiotherapy, Dr James Good, shares his insights into SABR These are unprecedented times in healthcare. The rapid global spread of a virus that affects both older people and younger people, poorly people and well people, will continue to have a profound impact on our economy and the way…

Read More

March 2020

26 March, 2020

Advanced radiotherapy in the treatment of breast cancer – reasons to be positive

Published in Jewish Chronicle Breast cancer is the most common cancer in women. According to Cancer Research UK, one in eight will be diagnosed with it at some point in their lifetime, although it is more likely to affect women beyond the age of 50. However, today more than ever, there is reason for optimism…

5 March, 2020

Coronavirus advice

GenesisCare, the NHS and Public Health England (PHE) are extremely well prepared for outbreaks of new infectious diseases. The NHS has put in place measures to ensure the safety of all patients and NHS staff while also ensuring services are available to the public as normal. The risk to the general public is moderate. If…

February 2020

December 2019

13 December, 2019

21st Century Oncology to join Australia’s GenesisCare in a partnership to increase access to high quality cancer care in U.S. communities

FLORIDA, U.S. – Cancer patients in communities across the U.S. are expected to benefit from increased access to high quality cancer care, with U.S. provider of radiation therapy and integrated cancer treatments, 21st Century Oncology, to become part of Australian cancer and cardiac care company, GenesisCare. The combined experience and reach of 21st Century Oncology’s…

10 December, 2019

GenesisCare UK brings MRIdian radiotherapy to the UK, shortening treatment time for prostate cancer and offering new hope to people with difficult to treat tumours

For the first time, patients in the UK now have access to MRIdian – the world’s smartest radiotherapy treatment – at GenesisCare’s treatment centre in Oxford.  This technology combines magnetic resonance imaging (MRI) techniques with extremely precise radiotherapy beams, enabling the clinician to visualise the exact position and shape of a patient’s tumour in real…

November 2019

13 November, 2019

Latest innovations in prostate cancer treatments in the UK

GenesisCare has recently worked with The Jewish Chronicle to raise awareness of our innovations in prostate cancer treatments in the UK.  Read our article that appeared in their November Health Supplement on Thursday 14th November 2019, where we take about the MRIdian Linac, spacing gels and 177Lutetium PSMA therapy. Prostate cancer is the most common…

October 2019

23 October, 2019

Patients to receive innovative treatments in new state-of-the-art cancer centre

Cancer patients will benefit from a £20 million investment that will see a new state-of-the-art diagnostic and treatment centre built in Surrey. Royal Surrey NHS Foundation Trust is working with specialist oncology group GenesisCare to provide the new facility, which is expected to open in late 2021. Eligible NHS patients and staff will have access…

September 2019

23 September, 2019

‘New hope for advanced prostate cancer patients’

GenesisCare has recently worked with Health Awareness UK and the Guardian on their Urology Health campaign. Read our article that appeared in the Guardian on Monday 23rd September 2019 where Yong Du, Clinical Director, Nuclear Medicine and Theranostics talks about how 177Lutetium PSMA therapy works and it’s benefits to men with late stage prostate cancer…